AbbVie unveils latest round of immunology scholarships for patients with chronic diseases – Endpoints News
Another 45 students with chronic immune-mediated diseases are going to college with a little help from AbbVie.
AbbVie on Thursday announced the winners of this year’s immunology fellowship, a group of students who have “exemplified their determination to overcome challenges,” AbbVie’s U.S. president of immunology, Patrick Horber, said in a statement. A press release.
Although best known for its portfolio of immunology drugs such as Rinvoq, Skyrizi or the blockbuster Humira – which faces an impending patent cliff – AbbVie launched its immunology scholarship program in 2016 to demonstrate its commitment to helping patients outside of dispensing prescriptions.
“The AbbVie Immunology Scholarship Program extends our passion for patient care by aiming to reduce the financial burden of students affected by inflammatory diseases as they pursue a life undefined by their diagnosis,” said a spokesperson. Terminal news in an email.
Since the program’s inception, AbbVie has distributed 300 scholarships, ranging from $5,000 for those pursuing an associate’s degree to $15,000 for students pursuing their bachelor’s, master’s, or doctoral degrees. This year alone, more than 1,000 patients applied.
AbbVie considers patients with a range of conditions including Ankylosing Spondylitis, Atopic Dermatitis, Crohn’s Disease, Hidradenitis Suppurativa, Juvenile Idiopathic Arthritis, Plaque Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, ulcerative colitis and uveitis.
Among this year’s recipients is Alaa-adeen Ahmad, a Capella University student with ankylosing spondylitis, an inflammatory condition that can cause the bones in the spine to fuse together, making the spine less flexible.
Ahmad was diagnosed a few years ago, after experiencing pain and muscle spasms. He is now pursuing a career in health care quality and safety management and is well on his way to earning his doctorate. He has already earned an MBA in Healthcare Management while working full time and treating his newly diagnosed illness.
“The AbbVie Immunology Scholarship will help me chart a course and grow my career in healthcare management while living with ankylosing spondylitis and supporting my young family,” Ahmad said in a statement.
AbbVie will begin accepting applicants for its next round of scholarships in October.